C. Debruyne
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in
- Oncology 24
- Lung Cancer Research Studies 12
- Cancer Immunotherapy and Biomarkers 7
-
- Lung Cancer Treatments and Mutations 10
- Occupational and environmental lung diseases 7
- Lung Cancer Diagnosis and Treatment 5
- Pleural and Pulmonary Diseases 4
- Co-authors
- Giuseppe Giaccone (27 shared papers)Jan P. van Meerbeeck (12 shared papers)Egbert Frederik Smit (8 shared papers)Bonne Biesma (7 shared papers)Desmond Curran (4 shared papers)Franz M.N.H. Schramel (5 shared papers)Rabab Mohamed Gaafar (5 shared papers)Nico van Zandwijk (9 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)European Journal of Cancer (8 papers)Annals of Oncology (5 papers)Lung Cancer (5 papers)The Lancet Oncology (2 papers)
- Partner nations
- BelgiumNetherlandsItaly
In The Last Decade
C. Debruyne
44 papers receiving 4.4k citations
C. Debruyne's Hit Papers
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 2.3k
- Genetics 699
- Oncology 1.6k
- Immunology 527
- Cancer Research 247
Countries citing papers authored by C. Debruyne
This map shows the geographic impact of C. Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Debruyne more than expected).
Fields of papers citing papers by C. Debruyne
This network shows the impact of papers produced by C. Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Debruyne. The network helps show where C. Debruyne may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Debruyne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma Hit paper breakdown → | 2002 | 750 |
| 2 | Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer Hit paper breakdown → | 2007 | 542 |
| 3 | Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada Hit paper breakdown → | 2005 | 512 |
| 4 | 2016 | 412 | |
| 5 | 2003 | 303 | |
| 6 | 1998 | 242 | |
| 7 | 2002 | 217 | |
| 8 | 2005 | 181 | |
| 9 | 2006 | 167 | |
| 10 | 2018 | 158 | |
| 11 | 1999 | 119 | |
| 12 | 2000 | 119 | |
| 13 | 2003 | 96 | |
| 14 | 2001 | 86 | |
| 15 | 2002 | 84 | |
| 16 | 1996 | 73 | |
| 17 | 1999 | 69 | |
| 18 | European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. | 2003 | 65 |
| 19 | 2003 | 52 | |
| 20 | 2003 | 50 |
About C. Debruyne
C. Debruyne is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Neurology and Cancer Research, having authored 45 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (10 papers), Occupational and environmental lung diseases (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (5 papers), Neuroblastoma Research and Treatments (4 papers) and Pleural and Pulmonary Diseases (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Genetics (699 citations), Oncology (1.6k citations), Immunology (527 citations) and Cancer Research (247 citations). C. Debruyne has collaborated with scholars based in Belgium, Netherlands and Italy. Frequent co-authors include Giuseppe Giaccone, Jan P. van Meerbeeck, Egbert Frederik Smit, Bonne Biesma, Desmond Curran, Franz M.N.H. Schramel, Rabab Mohamed Gaafar, Nico van Zandwijk, Catherine Legrand and Eric A. Van Marck. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.